Results 31 to 40 of about 22,786 (211)

Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol. [PDF]

open access: yes, 2020
AimTo show the characteristics and outcomes of patients with neovascular age-related macular degeneration (nAMD) who had extended remission (ER) while on a pro re nata (PRN) treatment protocol.MethodsThis was a retrospective case-control study of a ...
Amador-Patarroyo, Manuel J   +6 more
core  

Scalable molecular dynamics with NAMD on the Summit system [PDF]

open access: yesIBM Journal of Research and Development, 2018
NAMD (NAnoscale Molecular Dynamics) is a parallel molecular dynamics application that has been used to make breakthroughs in understanding the structure and dynamics of large biomolecular complexes, such as viruses like HIV and various types of influenza.
B. Acun   +5 more
openaire   +2 more sources

HALLS: An Energy-Efficient Highly Adaptable Last Level STT-RAM Cache for Multicore Systems [PDF]

open access: yes, 1968
Spin-Transfer Torque RAM (STT-RAM) is widely considered a promising alternative to SRAM in the memory hierarchy due to STT-RAM's non-volatility, low leakage power, high density, and fast read speed.
Adegbija, Tosiron, Kuan, Kyle
core   +4 more sources

Analysis of Systemic and Serum Risk Factors in Patients with Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

open access: yesOphthalmology and Therapy, 2023
Introduction It remains controversial whether polypoidal choroidal vasculopathy (PCV) represents a subtype of neovascular age-related macular degeneration (nAMD) or is a distinct disease entity.
Tianchang Tao   +8 more
doaj   +1 more source

Biodamage via shock waves initiated by irradiation with ions [PDF]

open access: yes, 2013
Radiation damage following the ionising radiation of tissue has different scenarios and mechanisms depending on the projectiles or radiation modality. We investigate the radiation damage effects due to shock waves produced by ions.
Solov'yov, Andrey V.   +2 more
core   +1 more source

Efficiency of anti-vascular endothelial growth factor drug switch in patients who did not respond to a series of bevacizumab injections

open access: yesIndian Journal of Ophthalmology
Purpose: To assess the effectiveness of switching anti-vascular endothelial growth factor (VEGF) agents in eyes with retinal pathologies that poorly respond to intravitreal bevacizumab injections.
Rotem Gindelskhi Sagiv   +5 more
doaj   +1 more source

High-throughput Binding Affinity Calculations at Extreme Scales [PDF]

open access: yes, 2018
Resistance to chemotherapy and molecularly targeted therapies is a major factor in limiting the effectiveness of cancer treatment. In many cases, resistance can be linked to genetic changes in target proteins, either pre-existing or evolutionarily ...
Balasubramanian, Vivek   +7 more
core   +3 more sources

Boosting Free-Energy Perturbation Calculations with GPU-Accelerated NAMD

open access: yesJournal of Chemical Information and Modeling, 2020
Harnessing the power of graphics processing units (GPUs) to accelerate molecular dynamics (MD) simulations in the context of free-energy calculations has been a longstanding effort toward the development of versatile, high-performance MD engines. We report a new GPU-based implementation in NAMD of free-energy perturbation (FEP), one of the oldest, most
Haochuan Chen   +6 more
openaire   +3 more sources

Management of neovascular age-related macular degeneration: Taiwan expert consensus

open access: yesJournal of the Formosan Medical Association, 2021
Neovascular age-related macular degeneration (nAMD) is a leading cause of irreversible vision loss. The present consensus provides suggestions on diagnosis, evaluation, treatment, and follow-up strategies for nAMD from a panel of 11 practicing ...
Ling Yeung   +10 more
doaj   +1 more source

New Therapies of Neovascular AMD—Beyond Anti-VEGFs

open access: yesVision, 2018
Neovascular age-related macular degeneration (nAMD) is one of the leading causes of blindness among the aging population. The current treatment options for nAMD include intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF ...
Praveen Yerramothu
doaj   +1 more source

Home - About - Disclaimer - Privacy